Around the world, 100 companies have debuted weight-loss medications, which have become a multimillion-dollar business. Novo Nordisk’s Ozempic is currently the best-known, but it’s far from the only option
The semaglutide craze is a global phenomenon, but among its unwanted side effects is a premature aging of the face. Health professionals have found themselves administering anti-aging treatments to an ever-younger clientele
Citi estimates that the fight against obesity will generate revenue of $158 billion in 2035. The main risk for the sector is the difficulty in guaranteeing supply
During trials, patients showed reduced appetite and even an aversion towards food generally. This has the potential to affect giant companies such as Nestlé and Cadbury
The Danish pharmaceutical company has become the most valuable business in Europe thanks to its products that combat the disease, which the WHO believes has ‘acquired pandemic proportions’
In recent years, many patients who inject GLP-1 agonists have claimed to have lost their desire to drink. Now studies explain the scientific basis behind their experience, opening the door to other addiction treatments